Trio Health Appoints Dave Bitner as Chief Commercial Officer

LOUISVILLE, CO. – Trio Health (Trio), a leading provider of clinical data solutions, has appointed Dave Bitner as its new Chief Commercial Officer (CCO). In this role, Bitner will spearhead Trio’s commercialization strategy and drive the development of innovative data solutions to support the evolving needs of life sciences clients and collaborators.

Dave brings nearly 30 years of experience in commercializing pharmaceuticals. Most recently, he spent six years at Komodo Health, where he held consulting and business development roles, contributing to the company’s rise as a major player in the claims data space.

Before Komodo, Bitner served as Head of Commercial Operations at Intercept Pharmaceuticals, Inc., where he was a key member of the Commercial Leadership Team. He supported the rare disease business in Primary Biliary Cholangitis (PBC) and helped prepare for the launch of their Nonalcoholic Steatohepatitis (NASH) indication. Prior to that, he held roles at major pharmaceutical manufacturers, including Regeneron Pharmaceuticals Inc., MSD (Europe), Merck & Co., Inc. (US), Amgen Inc., Pfizer Inc./Pharmacia, and NDC Health (now Symphony Health Inc). His expertise spans insights and analytics, business development and licensing (BD&L), and brand/portfolio strategy.

Widely recognized as a strategic connector and business development leader in healthcare technology and life sciences, Dave has a proven track record of forging strong relationships, identifying opportunities, and aligning clients with data-driven solutions that drive commercial success. His ability to bridge the gap between industry stakeholders—pharmaceutical manufacturers, healthcare providers, and technology innovators—has been instrumental in unlocking new growth opportunities. At Trio, Dave will play a pivotal role in expanding partnerships, enhancing client engagement, and shaping innovative offerings that support every stage of the biopharmaceutical product lifecycle.

“We are thrilled to welcome Dave to our leadership team,” said Brent Clough, CEO of Trio Health. “His extensive experience and strategic vision will be invaluable as we continue to drive our commercial efforts and expand our market presence. We are confident that he will play a key role in Trio’s growth and success.”

“I am excited to join Trio as they introduce new strategic partnerships and innovative clinical and commercial data solutions to the market,” said Dave. “I am particularly enthusiastic about the opportunity to pull EMR-level insights into tactical commercial solutions for our life sciences clients.”

About Trio Health

Trio Health is dedicated to improving patient care and outcomes by coordinating efforts among all patient care stakeholders. Its first-of-its-kind Multi-Disease Platform (MDX) tracks patients throughout their treatment journey, providing pharmaceutical and biotechnology companies, specialty pharmacies, and physicians with unparalleled data-driven insights. To learn more, visit www.triohealth.com.